The findings suggest there is considerable scope to improve awareness, with 70% of respondents believing more should be done to educate motorists about the potential dangers. Almost a quarter (24%) of drivers recognise that some everyday medicines can present risks behind the wheel comparable to illegal recreational drugs. However, awareness does not necessarily translate into behaviour. More than one in five (22%) know someone who takes these medications before driving, while 19% admit to having done so themselves.
The research also raised concerns about the physical effects of medication, with 6% of motorists saying they experienced drowsiness while driving after taking one of these treatments, while 15% believe the risks of driving after taking such medicines are exaggerated.
Paul Burgess, CEO at Startline Motor Finance, said: “It’s clearly a concern that four out of 10 drivers don’t know they could take perfectly legal medicines for conditions as common as colds and hay fever, and be affected to the extent they could fail a drug-driving test. Our research shows one in five people have taken these medicines and driven, and one in 20 have taken them and felt drowsy behind the wheel. This all supports the argument that more needs to be done to inform motorists about the dangers of drug-driving from prescribed and over-the-counter treatments.”
The Startline Used Car Tracker also explored whether motorists would reconsider taking medication if they needed to drive while unwell. When asked whether they would avoid taking medicine in order to get behind the wheel, 58% said they would choose not to take the treatment.
The findings come at a time when employers and fleet operators are facing increasing pressure to manage the risks associated with drivers breaching drink- and drug-driving legislation. Potential changes to drink-driving limits being considered by the Government, alongside a zero-tolerance approach to illegal drugs, are adding to the challenges fleet managers face.
Previous research by Fleet News highlighted how organisations are responding to the issue, with 84% of fleet respondents having a drug-driving policy in place. Of these, 66% have a dedicated drug-driving policy, while the remaining 18% address the issue as part of a wider driving policy.